Cannabis Search Engine Series
Cannabidiol | Cannabinoid | Cannabis Sativa | CBD - Marijuana | CO2 Extraction | Oil Separation | Supercritical CO2 Fluid Extraction search was updated real-time via Filemaker on:Cannabidiol | Cannabinoid | Cannabis Sativa | CBD - Marijuana | CO2 Extraction | Oil Separation | Supercritical CO2 Fluid Extraction | Return to Search List
Search Completed | Title | CONSUMERS PERCEPTIONS OF HEMP PRODUCTS FOR ANIMALS
Original File Name Searched: AHVMA-2016-V42-Hemp-Article.pdf | Google It | Yahoo | Bing
Text | CONSUMERS PERCEPTIONS OF HEMP PRODUCTS FOR ANIMALS | 001
Used with permission of the Journal of the American Holistic Veterinary Medical Association (JAHVMA). Article rst appeared in Volume 42, Spring Issue, 2016.
Scienti c Report
OF HEMP PRODUCTS FOR
Lori R. Kogan, PhD; Peter W. Hellyer, DVM, MS, DACVA, & Narda G. Robinson, DO, DVM, MS, FAAMA
From the Department of Clinical Sciences, the College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80526.
Address correspondence to Dr. Kogan at firstname.lastname@example.org
CBD — cannabidiol
CBDA — cannabidiolic acid
THC — delta-9 tetrahydrocannabinol THCA — tetrahydrocannabinolic acid
This study was designed to determine which hemp products pet owners are purchasing, reasons for their purchases, and the perceived value of these products on pets’ health. An anonymous online survey was given to pet owners who buy products from an online hemp company. Total responses were 632, of which 58.8% indicated they currently use a hemp product for their dog. Most dog owners (77.6%) indicated they use the product for an illness or condition diagnosed by a veterinarian, with the most common conditions including seizures, cancer, anxiety and arthritis. Fewer participants indicated they currently use hemp products for their cat (11.93%), with 81.8% indicating they use the product for a veterinarian-diagnosed illness or condition, most commonly cancer, anxiety and arthritis. The results of this study provide support for the growing number of anecdotal stories and offer guidance to researchers seeking to perform clinical studies on hemp in terms of its putative effectiveness and possible adverse outcomes. The information from this survey can serve as the basis for controlled clinical trials in areas including pain management, behavioral interventions for sleep disorders and anxiety for dogs, and pain management, in ammation reduction, and improvement in sleep patterns for cats.
The term “cannabis” refers to plants belonging to the genus Cannabis as well as those products designed for therapeutic applications (1). Cannabinoids can be administered in a variety of methods including orally, sublingually, or topically and either extracted naturally from the plant or manufactured synthetically (2).
Both hemp and marijuana originate from the Cannabis sativa plant. As such, both contain an array of plant-based chemicals called “cannabinoids,” including the 2 main cannabinoids, tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA). THCA, when dried or heated, converts to the psychoactive cannabinoid, delta-9 tetrahydrocannabinol (THC). Similarly, decarboxylation of CBDA yields cannabidiol (CBD). The main differences between hemp and marijuana are the ratio of THC to CBD, the amount of ber in the stalks, and the production of seeds for oil (3). By de nition, “industrial hemp,” the hemp of commerce which can be used for medicinal purposes, food, or ber content, contains high levels of CBD and less than 0.3% THC on a dry matter basis. By comparison, tests of some modern strains of marijuana reveal levels of THC greater than 20% and much
40 AHVMA Journal • Volume 42 Spring 2016
Image | CONSUMERS PERCEPTIONS OF HEMP PRODUCTS FOR ANIMALS
|Supercritical CO2 Fluid Extractor | Oil Extract Using Infinity Supercritical CO2 Extraction System - Botanical CO2 Extraction System - Go to website|
Search Engine Contact: email@example.com